US Stock MarketDetailed Quotes

IMNM Immunome

Watchlist
  • 15.610
  • +0.110+0.71%
Close May 13 16:00 ET
  • 15.750
  • +0.140+0.90%
Post 17:38 ET
935.72MMarket Cap-2901P/E (TTM)

About Immunome Company

Immunome, Inc. is a biopharmaceutical company, which engages in the discovery and development of antibody therapeutics products. It also focuses on oncology and infectious disease areas. The company was founded by Scott K. Dessain and Gregory P. Licholai on March 2, 2006 and is headquartered in Bothell, WA.

Company Profile

SymbolIMNM
Company NameImmunome
Listing DateOct 2, 2020
Issue Price12.00
Founded2006
CEODr. Clay B. Siegall,PhD
MarketNASDAQ
Employees55
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address18702 North Creek Parkway,Suite 100
CityBothell
ProvinceWashington
CountryUnited States of America
Zip Code98011
Phone1-610-321-3700
Websitehttp://www.immunome.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Clay B. Siegall,PhD
  • Chief Executive Officer, President and Chairman of the Board
  • 14.87M
  • Sandra G. Stoneman
  • Chief Legal Officer and General Counsel
  • --
  • Dr. Bruce Turner, M.D.,PhD
  • Chief Strategy Officer
  • --
  • Max Rosett
  • Principal Accounting Officer, Executive Vice President, Operations and Interim Chief Financial Officer
  • --
  • Kinney Horn
  • Chief Business Officer
  • --
  • Bob Lechleider
  • Chief Medical Officer
  • 2.92M
  • Dr. Jack Higgins, PhD
  • Chief Scientific Officer
  • 1.84M
  • Dr. Sandra M. Swain, M.D.
  • Director
  • --
  • Carol A. Schafer
  • Director
  • --
  • Philip Wagenheim
  • Director
  • 59.23K
  • Isaac Barchas, J.D.
  • Lead Independent Director
  • 296.59K
  • Jean-Jacques Bienaime
  • Independent Director
  • 287.93K
  • James P. Boylan, M.B.A.
  • Independent Director
  • 294.75K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg